Results 141 to 150 of about 3,877 (216)

Do newer drugs treat fewer diseases, controlling for time since launch? Evidence from France and the U.S. [PDF]

J Pharm Policy Pract
Lichtenberg FR.
europepmc   +1 more source

FECAL CALPROTECTIN AND INTESTINAL METABOLITES: WHAT IS THEIR IMPORTANCE IN THE ACTIVITY AND DIFFERENTIATION OF PATIENTS WITH INFLAMMATORY BOWEL DISEASES? [PDF]

Arq Bras Cir Dig
Lins LC, DE-Meira JEC, Pereira CW, Crispim AC, Gischewski MDR, Lins-Neto MÁF, Moura FA.   +6 more
europepmc   +1 more source

Evolution of illness severity in hospital admissions due to COVID-19, Québec, Canada, January to April 2022. [PDF]

Can Commun Dis Rep
Lo E, Fortin É, Gilca R, Trépanier PL, Geagea H, Zhou Z.   +5 more
europepmc   +1 more source

Persistent Fever after COVID-19 Vaccination in a Patient with Ulcerative Colitis: A Call for Attention. [PDF]

GE Port J Gastroenterol
Rodrigues CM, Carvalho AC, Ventura S, Domingues ÂP, Silva A, Ministro P.   +5 more
europepmc   +1 more source

IBD-PODCAST Portugal: Proportion of Patients with Suboptimal Disease Control and Its Impact on Quality of Life in Inflammatory Bowel Disease. [PDF]

GE Port J Gastroenterol
Tavares de Sousa H, Martins V, Ministro P, Rodrigues CM, Correia L, Bernardo S, Torres J, Nascimento CN, Lopes S, Oliveira C, Fernandes J, Prata R, Leitner C, Heatta-Speicher T, Magro F.   +14 more
europepmc   +1 more source

Diagnostic et prise en charge de la maladie cœliaque. [PDF]

CMAJ
Blom JJ, Gidrewicz D, Turner J, Duerksen DR, Pinto-Sánchez MI.   +4 more
europepmc   +1 more source

From Orofacial Granulomatosis to Crohn's Disease: A Case Report. [PDF]

GE Port J Gastroenterol
Teixeira MM, Antunes C, Pereira M, Sequeira C, Teixeira C, Freire R.   +5 more
europepmc   +1 more source

Steroid-Refractory Acute Severe Ulcerative Colitis in Infliximab-Experienced Patients. [PDF]

GE Port J Gastroenterol
Revés J, Bravo AC, Nascimento CN, Morão B, Frias-Gomes C, Roque Ramos L, Glória L, Torres J, Palmela C.   +8 more
europepmc   +1 more source